What is this medicine used for?
FDA-approved uses
- Appetite loss with weight loss from AIDS — Adults. Dronabinol can help a person feel hungry enough to eat.Oral capsule; Oral solution.
- Nausea and vomiting from chemotherapy — Adults. An option when other anti-nausea medicines have not given enough relief.Oral capsule; Oral solution.
What does the research say about PTSD nightmares?
The FDA has not approved dronabinol for nightmares related to post-traumatic stress disorder (PTSD). A 2026 study randomly assigned 171 adults with PTSD and recurrent nightmares to oral dronabinol or a placebo for 10 weeks. On a scale from 0 to 8 measuring how often nightmares happened and how intense they were, scores fell by an average of 3.7 points with dronabinol and 2.2 with placebo.
The study did not show a clear benefit for PTSD symptoms overall. Seven people in the dronabinol group and none in the placebo group had serious medical events. Investigators did not attribute those events to treatment. The study cannot tell us whether the benefit lasts with longer use.
The 2023 VA/DoD guideline recommends against cannabis and its derivatives for treating PTSD. That recommendation predates this trial.
What should I expect?
With capsules, effects may begin within about 30 to 60 minutes and can take several hours to peak. Follow the schedule on your prescription, including instructions about meals or chemotherapy.
Marinol is a capsule brand. Capsules come in 2.5 mg, 5 mg and 10 mg strengths and are swallowed whole.
Syndros is an oral liquid containing 5 mg per mL. Measure the prescribed volume with the supplied oral syringe and take it with a full glass of water. The label uses different doses for the liquid and capsules. Ask your pharmacist before changing forms.
How do I take it safely?
Marinol is a capsule brand. Capsules come in 2.5 mg, 5 mg and 10 mg strengths and are swallowed whole.
Syndros is an oral liquid containing 5 mg per mL. Measure the prescribed volume with the supplied oral syringe and take it with a full glass of water. The label uses different doses for the liquid and capsules. Ask your pharmacist before changing forms.
If you miss a dose, skip it if your next dose is close. Do not take two doses together. Ask your oncology team what to do if the missed dose was scheduled around chemotherapy. Discuss stopping after regular use with your prescriber because stopping suddenly can cause withdrawal symptoms.
What side effects should I know about?
- You may feel sleepy, dizzy or unusually high. It can be harder to concentrate, remember things or react quickly.
- Some people notice anxiety, suspicious thoughts, stomach discomfort or nausea. Tell your care team if these interfere with daily activities.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Marinol capsules
- View official prescribing information (opens in a new tab)Syndros oral solution
Which warning signs need help?
- Get emergency help for a seizure, trouble breathing or swelling of the face or throat. If a seizure occurs, stop taking dronabinol and seek care immediately.
- Contact your care team promptly if you faint, your heart races, you start seeing or hearing things others do not, or your mood or thinking changes sharply.
- Call your prescriber if vomiting or stomach pain gets worse while taking dronabinol. Repeated vomiting can cause dehydration.
What else should I know to stay safe?
- Tell your prescriber about any history of mania, depression or schizophrenia. Dronabinol can worsen these conditions. The labels advise avoiding use in people with a psychiatric history when possible and monitoring closely if treatment is necessary.
- Alcohol, opioids and sleep or anxiety medicines can increase drowsiness and confusion. Avoid drinking alcohol and wait to drive or use machinery until you know how dronabinol affects you.
- Avoid both forms if you have had an allergic reaction to dronabinol. The capsules contain sesame oil and the solution contains alcohol. A previous allergic reaction to the corresponding ingredient rules out that form.
- The oral solution contains alcohol. Its label rules out disulfiram or metronidazole during treatment, in the 14 days before starting the liquid and for 7 days after the last dose. If you need either medicine, contact your pharmacist or prescriber before taking it.
- Tell your care team about seizures, heart problems or a history of problems with alcohol or other drugs. Dronabinol can affect blood pressure and heart rate and can be habit-forming. Store it securely and never share it.
- Avoid dronabinol during pregnancy. If you are breastfeeding, ask your care team about a feeding plan for your particular product and condition. Safety and effectiveness have not been established in children. Older adults may be more sensitive to confusion and falls.
- If you miss a dose, skip it if your next dose is close. Do not take two doses together. Ask your oncology team what to do if the missed dose was scheduled around chemotherapy. Discuss stopping after regular use with your prescriber because stopping suddenly can cause withdrawal symptoms.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- For appetite loss, note whether eating becomes easier and share weight changes with your care team. If you are taking it with chemotherapy, record when nausea starts and whether you can keep fluids down.
- Let your pharmacist know if swallowing capsules is difficult. The liquid needs its own prescription instructions, measuring syringe and interaction check.
How does it work?
Nerve cells have places on their surface called cannabinoid receptors. THC can attach to these receptors and turn them on. This changes signals involved in hunger and nausea. It can also change how alert you feel, how you perceive things and how well you can keep your balance.
How was this medicine developed?
The first US approval for dronabinol was in 1985. It gave clinicians a way to prescribe a measured amount of THC in a capsule. A liquid formulation followed, giving people who have trouble swallowing capsules another way to take the medicine.
Both products have labels for specific symptoms associated with AIDS or cancer chemotherapy. More recently, researchers have asked whether the same molecule might ease nightmares in people with post-traumatic stress disorder. That is a separate question from whether dronabinol can treat PTSD as a whole.
The 2026 trial measured the frequency and intensity of nightmares and followed participants during ten weeks of treatment.
How do I say the name?
Dronabinol: droe-NAB-ih-nol. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Marinol
Oral capsule
Marinol is a capsule brand. Capsules come in 2.5 mg, 5 mg and 10 mg strengths and are swallowed whole.
Official product information: Marinol — U.S. official label (DailyMed)
Syndros
Oral solution
Syndros is an oral liquid containing 5 mg per mL. Measure the prescribed volume with the supplied oral syringe and take it with a full glass of water. The label uses different doses for the liquid and capsules. Ask your pharmacist before changing forms.
Official product information: Syndros — U.S. official label (DailyMed)
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Marinol capsules, US prescribing information
- Syndros oral solution, US prescribing information
- Dronabinol capsule label
- Dronabinol patient guide
- Dronabinol for nightmares in post-traumatic stress disorder, 2026 randomized trial
- Clinician’s Guide to Medications for PTSD
- ISMP List of Confused Drug Names, page 4
- Dronabinol (oral), patient information
- Tetrahydrocannabinol, PubChem compound 16078
- Droperidol injection, US product label
- FDA and Cannabis: Research and Drug Approval Process
- Marinol: Package Insert / Prescribing Information / MOA
Giving medicine safely to children: family guide (PDF, 3 pages)

